Date Name Title Filing Type Shares Traded Price Total Held
Apr 04, 2011
SVP Res and Dev Sciences
SVP Res and Dev Sciences Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 92,308 -- --
Mar 30, 2011
SVP Res and Dev Sciences
SVP Res and Dev Sciences Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 7,692 -- --
Jul 24, 2009
SVP Res and Dev Sciences
SVP Res and Dev Sciences Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,537 -- --
Jul 24, 2009
SVP Res and Dev Sciences
SVP Res and Dev Sciences Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 89,463 -- --
Sep 29, 2008
SVP, Research & Devel Sciences
SVP, Research & Devel Sciences Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 25,000 -- --
Oct 31, 2006
SVP, Therap & Clin Prog Dev
SVP, Therap & Clin Prog Dev Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,000 -- --
Oct 31, 2006
SVP, Therap & Clin Prog Dev
SVP, Therap & Clin Prog Dev Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 48 -- --
Oct 31, 2006
SVP, Therap & Clin Prog Dev
SVP, Therap & Clin Prog Dev Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 18,311 -- --
Feb 03, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 16,000 -- --
Feb 03, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 24,000 -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.